Tag: Infectious disease

  • COVID Vaccines: The Current and Projected Status

    Key Points: In today’s Recommendations for Industry, we discuss the current and projected status of COVID-19 vaccines. Read more below. COVID-19 Was Third Leading Cause of Death in U.S. last year. In 2021, COVID-19 was the third leading cause of death in the U.S., as the Delta and Omicron waves drove the pandemic’s death toll…

  • CDC Map Showing Low COVID Levels Across 94% of U.S.

    Key Points: In today’s Recommendations for Industry, we discuss low COVID levels across much of the U.S. with some regional levels of BA.2.12. Read more below. DOJ appeals federal ruling on transportation mask mandate. The Justice Department on Wednesday appealed a ruling by a federal judge that struck down the mask mandate for mass transportation,…

  • Travel Mask Mandate “Outlawed” – What this Means to your Business

    Key Points: In today’s Recommendations for Industry, we discuss the dropping of the travel mask mandate. Read more below. Declaring the COVID-19 travel mask mandate to be unlawful, U.S. District Judge Kathryn Kimball Mizelle in Tampa said the mandate exceeded the authority granted to the CDC under federal public health law; that Congress had never…

  • COVID Levels – Follow the Curve

    Key Points: In today’s Recommendations for Industry, we discuss following the curve. Read more below. Extending TSA mask mandate ‘absolutely’ still on the table. On Monday, a top White House COVID-19 adviser said that extending the federal mask mandate for all transportation networks, which is set to expire April 18, is “absolutely” under consideration. Centers…

  • Cases decreasing: Maintain Course

    Key Points: In today’s Recommendations for Industry, we discuss decreasing COVID cases and advice to maintain the course. Read more below. A recent Duke University study has found that US healthcare workers “had similar rates of potential moral injury – a type of trauma-induced wound to the psyche – as military combat veterans” leading to…

  • New England Cases Rise – What’s It Really Mean?

    Key Points: In today’s Recommendations for Industry, we discuss what the COVID case increase in the New England States means for the U.S. Read more below. New England states are reporting a sharp increase in daily COVID-19 cases driven by the Omicron subvariant, BA.2. This rise in numbers (up to and over 40% in cases)…

  • U.S. Seeing Only a Blip in Cases Despite BA.2 Dominance

    Key Points: In today’s Recommendations for Industry, we discuss the “blip” in U.S. COVID cases, despite the fact that BA.2 has become the dominant variant. Read more below. FDA Authorizes Second Booster for Older and Immunocompromised Individuals. FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people…

  • Global COVID Flattening, Showing No Rise in U.S.

    Key Points: In today’s Recommendations for Industry, we discuss the flattening of global COVID cases. Read more below. Asian COVID hot spots show signs of improvement. The pace of COVID-19 spread appears to be slowing in some of Asia’s recent hot spots, including Hong Kong, where the number of daily cases has been declining since…

  • Trends Indicate Slight Nudge (not surge) in U.S. COVID Cases

    Key Points: In today’s Recommendations for Industry, we discuss TAG’s interpretation of COVID trends being seen in TAG’s matrix and other news indicating a “nudge” – not a surge – in the US. Read more below. Weekly WHO Update: Global COVID-19 cases climb for second week in a row. Led mainly by surges in Asian…

  • On the whole: Each week is looking better!

    Key Points: In today’s Recommendations for Industry, we have a short discussion on increasing influenza cases around the US (as you’ll see in the Influenza Update below) and also how COVID-19 is trending across the country. Read more below. The WHO is encouraging countries, “especially those that have received the multiplex influenza and SARS-CoV-2 reagent…